about
The conditional KO approach: Cre/Lox technology in human neuronsAnalysis of conditional heterozygous STXBP1 mutations in human neuronsRapid single-step induction of functional neurons from human pluripotent stem cellsConcise Review: Patient-Specific Stem Cells to Interrogate Inherited Eye DiseaseInduced Pluripotency and Gene Editing in Disease Modelling: Perspectives and ChallengesThe Use of Induced Pluripotent Stem Cell Technology to Advance Autism Research and TreatmentEnhanced Reprogramming Efficiency and Kinetics of Induced Pluripotent Stem Cells Derived from Human Duchenne Muscular DystrophyParkinson-associated risk variant in distal enhancer of α-synuclein modulates target gene expressionModeling human brain development with cerebral organoidsTechnology advancement for integrative stem cell analysesLaying a solid foundation for Manhattan--'setting the functional basis for the post-GWAS era'.Human intestinal tissue with adult stem cell properties derived from pluripotent stem cells.Global transcriptional and translational repression in human-embryonic-stem-cell-derived Rett syndrome neurons.The Promise and Challenge of Induced Pluripotent Stem Cells for Cardiovascular Applications.Patient-derived skeletal dysplasia induced pluripotent stem cells display abnormal chondrogenic marker expression and regulation by BMP2 and TGFβ1Mechanisms and models of somatic cell reprogramming.Generation of human striatal neurons by microRNA-dependent direct conversion of fibroblastsInduced Pluripotent Stem Cells Meet Genome EditingPath from schizophrenia genomics to biology: gene regulation and perturbation in neurons derived from induced pluripotent stem cells and genome editing.Genomics in neurological disorders.Derivation of Patient Specific Pluripotent Stem Cells Using Clinically Discarded Cumulus CellsDirect conversion of mouse fibroblasts to GABAergic neurons with combined medium without the introduction of transcription factors or miRNAsMolecular heterogeneity of midbrain dopaminergic neurons--Moving toward single cell resolution.PTEN deficiency reprogrammes human neural stem cells towards a glioblastoma stem cell-like phenotypeThe Use of Induced Pluripotent Stem Cells for the Study and Treatment of Liver Diseases.Minireview: Genome Editing of Human Pluripotent Stem Cells for Modeling Metabolic Disease.Functional vascular endothelium derived from human induced pluripotent stem cells.A cut above the rest: targeted genome editing technologies in human pluripotent stem cells.Low-dose acetaminophen induces early disruption of cell-cell tight junctions in human hepatic cells and mouse liver.New and TALENted genome engineering toolbox.The potential of stem cell research for the treatment of neuronal damage in glaucoma.iPS cells: a game changer for future medicine.Approaches to in vitro tissue regeneration with application for human disease modeling and drug development.Induced pluripotent stem cells as a discovery tool for Alzheimer׳s disease.Modeling Alzheimer's disease with human induced pluripotent stem (iPS) cells.CREB Signaling Is Involved in Rett Syndrome PathogenesisModeling autism spectrum disorders with human neurons.Concise Review: Liver Regenerative Medicine: From Hepatocyte Transplantation to Bioartificial Livers and Bioengineered Grafts.Elucidating the role of the A2A adenosine receptor in neurodegeneration using neurons derived from Huntington's disease iPSCs.NF-κB activation impairs somatic cell reprogramming in ageing.
P2860
Q26269819-B6722BB1-70F8-41EC-9868-2898BF3351FEQ26269829-16F439A9-5683-444D-85FD-3B79772CD5D1Q26269862-5530D20F-CF49-4AD0-B288-FA3DC73D2D0FQ26774786-AD4B590F-1DD1-4CEE-9C8D-91E8D318EC26Q26775061-53AEA7B3-0F09-46C4-9EAE-C1B9E6FFE378Q28081659-7D9B4D89-D8F2-4F59-8F0A-BF6DA3DE7CE7Q28550776-0C6F2341-5CF8-4DA7-BDEE-8E0176059F21Q28598223-A1B849A7-AA45-4B05-AB13-F02B53C36DF6Q28973623-3EACC4A7-27DF-4C5A-B0E7-C069EC79483CQ30397631-B01BB4D7-594B-43C5-B053-8C70DB4A6AC5Q33631309-FFCA7DFB-A3E4-4600-8D2B-614A309585F8Q33729666-CA7E2CDC-E01E-45A2-B7A4-0BFA93221386Q33740090-F6A4E19D-E9A7-4096-8CA7-A26ADF0807D3Q33748399-18DB2B68-6FA7-44D1-8842-3A880CE6E6DDQ33788974-0FD4B839-54FA-49C0-8DA6-EE7B3A4B8616Q34345169-11FF3A76-B0B5-4B3A-8231-00451FAE0AD7Q34469252-636B7173-991C-4921-9B4A-98C5A5398450Q34525438-7CA062A6-260A-47FF-8103-245DBD294670Q35095120-0E0F33D0-4220-4906-BC83-D76064D62F77Q35543494-A7B01453-FC99-4954-805D-BB167A539F03Q36179402-34675FCC-098F-4E65-8C4B-A44DDD7F5670Q36189440-1C1C966E-6AE5-43EA-9203-34F481E3FAD1Q36373006-D23B0A78-A7A9-44FB-A031-BE174619D580Q36392356-077FD613-4795-4D24-9A95-2BD5058A1DC9Q36695546-E0BBA69E-3107-4851-848E-D4204816FE39Q36945218-B0B8BBEE-E5E0-4B8F-803E-1B9B9ABFBC53Q37133657-C2ED4856-69A7-4B90-9455-EE2ED5896640Q37596293-6F2ABBEF-D18D-4805-B909-C6429E0E007DQ37612385-EBF415F7-192E-4C22-9148-C2F94E6BE645Q37662636-63EF0A49-0E40-4C3E-B24F-1BA5A1508468Q38109499-4D886B4C-EBDF-4D54-8192-A6B7559A58A0Q38185513-962DCDE5-D095-400F-B489-A02F5A10448DQ38209078-918D905D-7ED9-404C-9F87-AC7A568CD0B2Q38605546-1E80F1E5-0ACB-48DE-962C-C1068F63CFB5Q38666481-CD5951DB-CDBF-4126-93E4-AD23335A0A08Q38713212-5D3B6B32-03B1-42BB-B6C7-6D4B6EDE2204Q38725769-D5DF02BF-FB34-4BC3-8E0E-A5E52A8D2855Q38820033-DD83C20C-1DD4-4D99-B2A8-80B0761B1DB2Q38844409-B0D98309-4ED1-44A7-8708-D78301BC8437Q38848975-5C716047-A53E-4AC2-BAF0-DC7039DB6BA0
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Medicine. iPSC disease modeling.
@en
Medicine. iPSC disease modeling.
@nl
type
label
Medicine. iPSC disease modeling.
@en
Medicine. iPSC disease modeling.
@nl
prefLabel
Medicine. iPSC disease modeling.
@en
Medicine. iPSC disease modeling.
@nl
P356
P1433
P1476
Medicine. iPSC disease modeling.
@en
P2093
Frank Soldner
P304
P356
10.1126/SCIENCE.1227682
P407
P577
2012-11-01T00:00:00Z